PharmaCyte Biotech (PMCB) FCF Margin (QoQ) (2010 - 2012)
PharmaCyte Biotech (PMCB) FCF Margin (QoQ) (2010 - 2012) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | PharmaCyte Biotech | 4.48 Mn | 4.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2012 | -5,524.00 |
| Jul 31, 2012 | -51,103.00 |
| Apr 30, 2012 | -59,937.00 |
| Jan 31, 2012 | 8,159.00 |
| Oct 31, 2011 | 34,547.00 |
| Jul 31, 2011 | -32,795.00 |
| Apr 30, 2011 | -6,217.00 |
| Jan 31, 2011 | -20,717.00 |
| Oct 31, 2010 | 4,081.00 |